AI improves diagnosis, reduces false positives from mammo images
Radiologists getting an assist from artificial intelligence can detect more breast cancer—with a reduced rate of false positive incidents—from mammography images.
Radiologists getting an assist from artificial intelligence can detect more breast cancer—with a reduced rate of false positive incidents—from mammography images.
AI’s ability to interpret data relies on processes that are not transparent, making it difficult to verify and trust outputs from AI systems.
The Food and Drug Administration has given its clearance to software to help clinicians acquire standard views of the heart from different angles to diagnosis cardiac conditions.
Researchers at two companies say they have developed an artificial intelligence platform intended to aid pathologists who use images to classify subtypes of lung cancer.
The Food and Drug Administration has given clearance to algorithms for the detection of atrial fibrillation and heart murmurs, when used in combination with a digital stethoscope.
A new program at Purdue University aims to improve health outcomes by applying real-time physiological data from wearable sensors.
Organizations frequently ask how they can become great at scaling AI. Here’s are the key elements to consider if you want to scale AI well, repeatedly.
A third of American hospitals and imaging centers are already implementing artificial intelligence, machine learning or deep learning in radiology.
A five-year, $40 million program funded by Microsoft will leverage artificial intelligence to accelerate medical research and to improve access to care for underserved populations.
An interactive voice application that leverages artificial intelligence is able to track the clinical state of patients with serious mental illness by analyzing their speech samples.
IBM called for rules aimed at eliminating bias in artificial intelligence to ease concerns that the technology relies on data that bakes in past discriminatory practices and could harm women, minorities, the disabled, older Americans and others.
While machine learning has the potential to identify new treatments, reduce failure rates in clinical trials and improve drug development, a lack of high-quality data is hindering the use of the technology.